Animal-Assisted Therapy in Patients With Schizophrenia

NCT04476836 | Unknown

• 1 other identifier: 202000549B0
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

Animal-assisted therapy (AAT) can be helpful to improve the psychiatric, emotional, physical,and social status in patients with physical and mental illness and the elderly. The study aims to investigate the effects of AAT program in middle-aged and older patients with schizophrenia. The investigators will recruit 40 patients with schizophrenia in psychiatric ward randomised into AAT group and control group. AAT group will complete the 12-week program. This study contains two assessment sessions before and after intervention, including PANSS, ACIS, MoCA-T, CHI, DASS-21, CST, TUG and 5MWT.

Conditions

Schizophrenia; Animal-assisted Therapy

Keywords

schizophrenia; animal-assisted therapy

Outcome Measures

Primary Outcomes (1)

• Change scores of Positive and Negative Syndrome Scale

  This test is used for measuring symptom severity of patients with schizophrenia.

  Baseline, immediate after treatment

Secondary Outcomes (7)

• Change scores of The Assessment of Communication and Interaction Skills

  Baseline, immediate after treatment

• Change scores of The Taiwanese version of Montreal Cognitive Assessment

  Baseline, immediate after treatment

• Change scores of Chinese Happiness Inventory

  Baseline, immediate after treatment

• Change scores of Depression Anxiety Stress Scales-21

  Baseline, immediate after treatment

• Change scores of Chair Stand Test

  Baseline, immediate after treatment

Study Arms (2)

AAT group

EXPERIMENTAL

Animal-assisted therapy will be provided one 1-hour session per week for 48 weeks.

Other: Animal-Assisted Therapy

control group

NO INTERVENTION

routine care

Interventions

Animal-Assisted Therapy OTHER

Animal-Assisted Therapy is when animals are used in goal-directed treatment sessions. These goals can be physical, mental, emotional or social.

AAT group

Eligibility Criteria

• Age: 40 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Having a diagnosis of schizophrenia according to the DSM-5.
• Adult aged 40 years or older.
• Having stable physical and psychological health conditions based on master clinician judgment.
• Having the will to participate in the study after thorough comprehension of the content.
• Not receiving treatment protocol last half a year.

You may not qualify if:

• Severe cognitive impairment e.g. aphasia, being unable to follow 3 or more orders.
• Being allergic to animals.
• History of Asthma.
• Coagulation disorders
• presenting symptoms of specific phobia, anxiety disorder and obsessive-compulsive disorder in context of dog, infection and contamination.

Sponsors & Collaborators

• Chang Gung Memorial Hospital: lead

Study Sites (1)

Chang Gung Memorial Hospital, Kaohsiung Medical Center

Kaohsiung City, 833, Taiwan

Location

MeSH Terms

Conditions

Schizophrenia

Interventions

Animal Assisted Therapy

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic Disorders; Mental Disorders

Intervention Hierarchy (Ancestors)

Rehabilitation; Aftercare; Continuity of Patient Care; Patient Care; Therapeutics; Physical Therapy Modalities; Psychotherapy; Behavioral Disciplines and Activities; Health Services; Health Care Facilities Workforce and Services

Central Study Contacts

Chyi-Rong Chen, Master

CONTACT

+886-7-7317123; ccr776@cgmh.org.tw

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: INVESTIGATOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 16, 2020
• First Posted: July 20, 2020
• Study Start: August 1, 2020
• Primary Completion: August 24, 2020
• Study Completion: December 1, 2020
• Last Updated: July 20, 2020

Record last verified: 2020-07

Locations

TW (1)